Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pei Shi

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
Cancer Letters|July 28, 2016
A novel combinatorial strategy using Seliciclib(®) and Belinostat(®) for eradication of non-small cell lung cancer via apoptosis induction and BID activationPei-Shi Ong, Lingzhi Wang, Deborah Miao-Hui Chia, et al.
JMIR Mhealth and Uhealth|March 15, 2019
Perspectives on Acceptance and Use of a Mobile Health Intervention for the Prevention of Atherosclerotic Cardiovascular Disease in Singapore: Mixed-Methods StudyVictoria Haldane, Yao Guo Tan, Krichelle Wei Qi Teo, et al.
Scientific Reports|December 14, 2021
Transgenic refractory Aedes aegypti lines are resistant to multiple serotypes of dengue virusWei-Liang Liu, Chia-Wei Hsu, Shih-Peng Chan, et al.
Journal of Infection and Public Health|March 17, 2023
Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic reviewYong-Bo Zheng, Na Zeng, Kai Yuan, et al.
JMIR Mhealth and Uhealth|May 30, 2019
User Preferences and Persona Design for an mHealth Intervention to Support Adherence to Cardiovascular Disease Medication in Singapore: A Multi-Method StudyVictoria Haldane, Joel Jun Kai Koh, Aastha Srivastava, et al.
The Lancet. Gastroenterology & Hepatology|January 9, 2022
Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trialXiangrui Meng, Tao Wu, Yonggui Hong, et al.
Chemico-Biological Interactions|July 6, 2019
Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseasesDinesh Kumar Chellappan, Quinnie Ling Sze Ning, Sandra Khoo Su Min, et al.
Cancer Letters|January 7, 2018
Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signalingLingzhi Wang, Nicholas Li-Xun Syn, Vinod Vijay Subhash, et al.
Sleep Medicine Reviews|August 17, 2024
To nap or not? Evidence from a meta-analysis of cohort studies of habitual daytime napping and health outcomesYing-Bo Yang, Yong-Bo Zheng, Jie Sun, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Cancer Letters|July 28, 2016
A novel combinatorial strategy using Seliciclib(®) and Belinostat(®) for eradication of non-small cell lung cancer via apoptosis induction and BID activationPei-Shi Ong, Lingzhi Wang, Deborah Miao-Hui Chia, et al.
JMIR Mhealth and Uhealth|March 15, 2019
Perspectives on Acceptance and Use of a Mobile Health Intervention for the Prevention of Atherosclerotic Cardiovascular Disease in Singapore: Mixed-Methods StudyVictoria Haldane, Yao Guo Tan, Krichelle Wei Qi Teo, et al.
Scientific Reports|December 14, 2021
Transgenic refractory Aedes aegypti lines are resistant to multiple serotypes of dengue virusWei-Liang Liu, Chia-Wei Hsu, Shih-Peng Chan, et al.
Journal of Infection and Public Health|March 17, 2023
Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic reviewYong-Bo Zheng, Na Zeng, Kai Yuan, et al.
JMIR Mhealth and Uhealth|May 30, 2019
User Preferences and Persona Design for an mHealth Intervention to Support Adherence to Cardiovascular Disease Medication in Singapore: A Multi-Method StudyVictoria Haldane, Joel Jun Kai Koh, Aastha Srivastava, et al.
The Lancet. Gastroenterology & Hepatology|January 9, 2022
Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trialXiangrui Meng, Tao Wu, Yonggui Hong, et al.
Chemico-Biological Interactions|July 6, 2019
Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseasesDinesh Kumar Chellappan, Quinnie Ling Sze Ning, Sandra Khoo Su Min, et al.
Cancer Letters|January 7, 2018
Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signalingLingzhi Wang, Nicholas Li-Xun Syn, Vinod Vijay Subhash, et al.
Sleep Medicine Reviews|August 17, 2024
To nap or not? Evidence from a meta-analysis of cohort studies of habitual daytime napping and health outcomesYing-Bo Yang, Yong-Bo Zheng, Jie Sun, et al.
Pageof 16